Anticoagulant Heparin Solution
» Anticoagulant Heparin Solution is a sterile solution of Heparin Sodium in Sodium Chloride Injection. Its potency is not less than 90.0 percent and not more than 110.0 percent of the potency stated on the label in terms of USP Heparin Units. It contains not less than 0.85 percent and not more than 0.95 percent of sodium chloride (NaCl). It may be buffered. It contains no antimicrobial agents.
Heparin Sodium 75,000 Units
Sodium Chloride Injection, a
sufficient quantity to make
1000 mL
Add the Heparin Sodium, in solid form or in solution, to the Sodium Chloride Injection, mix, filter if necessary, and sterilize.
Packaging and storage— Preserve in single-dose containers, of colorless, transparent, Type I or Type II glass, or of a suitable plastic material (see Transfusion and Infusion Assemblies and Similar Medical Devices 161).
Labeling— Label it in terms of USP Heparin Units, and to indicate the number of mL of Solution required per 100 mL of whole blood.
Bacterial endotoxins 85 It contains not more than 2.5 USP Endotoxin Units per mL.
pH 791: between 5.0 and 7.5.
Other requirements— It meets the requirements under Injections 1.
Assay for heparin sodium— Proceed as directed in the Assay under Heparin Sodium Injection, substituting Anticoagulant Heparin Solution for the Injection.
Assay for sodium chloride— Pipet 10 mL of Solution into a suitable container, add 2 mL of potassium chromate TS, and titrate with 0.1 N silver nitrate VS. Each mL of 0.1 N silver nitrate is equivalent to 5.844 mg of NaCl.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Anita Y. Szajek, Ph.D.
Senior Scientist
(BBBBP05) Biologics and Biotechnology - Blood and Blood Products
Reference Standards Lili Wang, Technical Services Scientist
85 Radhakrishna S Tirumalai, Ph.D.
Senior Scientist
(MSA05) Microbiology and Sterility Assurance
USP32–NF27 Page 1566